Some studies have shown upregulated COL17A1 in ductal breast cancers, prostate carcinoma, cutaneous squamous cell, and basal cell carcinomas [9] and in cervical cancer and squamous cell carcinomas [30–34]. This evidence concerns the gene COL17A1 and cervical carcinoma.